Wysenski Retirement, New Chief Legal Officer Add Another Layer To CF Data-Error Story At Vertex
This article was originally published in The Pink Sheet Daily
Executive Summary
While Wall Street seems to have forgiven Vertex for mistakenly reporting better breathing-improvement data than actually was the case for an experimental cystic fibrosis drug, questions about executives who sold stock before the data correction are raising eyebrows in Congress and at the SEC.